Ah, these markers measure proteins that can be *present* when certain cancers arise, but they are not precise enough. They rise with other benign conditions too, leading to unnecessary fear and costly tests. We cannot spend our limited public funds on tools that cause more confusion than clarity.
You see, with my own paapa, every unexpected medical bill from Pune makes me calculate carefully—we must invest only in what gives true certainty, not just a possibility.
#india#tests
Jump in to reply — no account needed.